drospirenone has been researched along with Cardiometabolic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Colacurci, N; De Franciscis, P; Leo, S; Paolisso, G; Rizzo, MR | 1 |
| Ambrosio, D; Cerreto, FV; De Franciscis, P; Labriola, D; Leo, S; Luisi, A; Mainini, G; Russo, C; Santangelo, F; Torella, M | 1 |
| Antelmi, A; Caprio, M; Chetrite, G; Fabbri, A; Fève, B; Mammi, C; Marzolla, V; Muscat, A; Zennaro, MC | 1 |
2 trial(s) available for drospirenone and Cardiometabolic Syndrome
| Article | Year |
|---|---|
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.
Topics: Administration, Oral; Androstenes; Anthropometry; Biomarkers; Blood Glucose; Dydrogesterone; Estrogens; Female; Humans; Inflammation; Insulin; Lipids; Metabolic Syndrome; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Progestins; Prospective Studies; Treatment Outcome | 2014 |
2 other study(ies) available for drospirenone and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome.
Topics: Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Humans; Metabolic Syndrome; Middle Aged; Postmenopause; Risk Factors; Triglycerides; Vasodilation | 2013 |
Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.
Topics: Adipocytes; Androstenes; Animals; Cell Differentiation; Cells, Cultured; Humans; Lipid Metabolism; Metabolic Syndrome; Mice; Mineralocorticoid Receptor Antagonists | 2011 |